- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04669795
Osteogenic Potential of Cissus Quadrangularis Alveolar Ridge Distraction
Evaluation of Osteogenic Potential of Cissus Quadrangularis on Mandibular Alveolar Ridge Distraction
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
OPGs were taken immediately after distractor placement, at end of activation period, at 1st,2nd month of consolidation period, and at end of consolidation period. Change in bone height was evaluated immediately after distractor placement, at end of activation and end of consolidation periods.
CBCT were taken immediately after implant installation, and 6 months later to evaluate change bone density and marginal bone level about the dental implant.
histological evaluation was done by biopsy obtained, by trephine bur, from implant site during its preparation. The bone biopsy fixed in 4% formalin solution for 7 days, rinsed in water, and dehydrated in sequent phases of ethanol (70, 80, 90, and 100%) and then specimens were stained by hematoxylin- eosin for microscopic evaluation.
Radiographic evaluation
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Nasr City
-
Cairo, Nasr City, Egypt, 11651
- Faculty of dental medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients were included if they were free from any disease that may affect healing. Also, presented with 2-3 missing teeth at least in posterior area and CBCT showed bone height above inferior alveolar canal (IAC) ranged 8-10mm.
Exclusion Criteria:
- patients were excluded if they suffered from any disease affect tissue healing, bad oral hygiene or heavy smoking patients
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Group 1
Placebo was given to ten patients during consolidation period ( 2 capsule daily for 6 months during consolidation period)
|
Drug with osteogenic potential given to the patients after consolidation period.
dose was two capsules once /day with meals for 6 weeks
Other Names:
|
Experimental: Group 2
Cissus quadrangularis in form of capsules given to ten patients ( 2 capsule daily for 6 months during consolidation period)
|
Drug with osteogenic potential given to the patients after consolidation period.
dose was two capsules once /day with meals for 6 weeks
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Bone gain after distraction
Time Frame: immediately at end of distractor activation
|
Increase in bone height after distraction
|
immediately at end of distractor activation
|
Relapse after distraction
Time Frame: 3 months from beginning of consolidation period
|
Relapse evaluated on panorama
|
3 months from beginning of consolidation period
|
Crestal bone loss around dental implant
Time Frame: 6 months from implant placement
|
By using cone beam CT, crestal bone level around implant evaluated by measuring a distance from implant apex to a point on dental implant where bone contacts the dental implant mesially and distally.
then average of bone loss round each implant was obtained.
|
6 months from implant placement
|
Bone density around dental implant
Time Frame: 6 months from implant placement
|
By using cone beam CT, bone density assessed around dental implant at crestal, middle, and apical portions then average was obtained
|
6 months from implant placement
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Altaweel, Al-Alharby university
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Al-AlAzhar University
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dental Implant
-
ORHUN EKRENCompletedDental Implant | Short Dental Implant
-
Università degli Studi di SassariDr. Dario Melodia; Dr. Milena Pisano; Prof. Silvio Mario Meloni; Prof. Edoardo... and other collaboratorsNot yet recruiting
-
Università degli Studi di SassariDr. Dario Melodia; Dr. Milena Pisano; Dr. Aurea Lumbau; Prof. Silvio Mario Meloni; Prof. Edoardo BaldoniNot yet recruiting
-
Istanbul Medipol University HospitalCompletedDental Implant Failed | Osseointegration Failure of Dental ImplantTurkey
-
The University of Texas Health Science Center,...CompletedDental Implant | Soft Tissue Augmentation | Immediate Dental ImplantUnited States
-
Biotech DentalRecruitingDental Implant | Dental Restoration | Dentistry | Implant-supported Fixed ProsthesisFrance
-
University of Sao PauloCompletedDental Implant Failed | Pre-osseointegration Failure of Dental ImplantBrazil
-
Kafrelsheikh UniversityRecruitingDental Implant Failed | Implant ComplicationEgypt
-
Qassim UniversityCompletedDental Implant | Dental ExtractionSaudi Arabia
-
Ahram Canadian UniversityAl Hayah University in CairoRecruitingDental Implantation | Dental Implant | Surgical Dental ProsthesesEgypt
Clinical Trials on Cissus Quadrangularis
-
Gateway Health AllianceCompletedObesity | Overweight | Dyslipidemia